Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

Trends in health care-associated infections in acute care hospitals in Canada: an analysis of repeated point-prevalence surveys.

Mitchell R, Taylor G, Rudnick W, Alexandre S, Bush K, Forrester L, Frenette C, Granfield B, Gravel-Tropper D, Happe J, John M, Lavallee C, McGeer A, Mertz D, Pelude L, Science M, Simor A, Smith S, Suh KN, Vayalumkal J, Wong A, Amaratunga K; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2019 Sep 9;191(36):E981-E988. doi: 10.1503/cmaj.190361.

PMID:
31501180
2.

Epidemiology of Clostridioides difficile infection in Canada: A six-year review to support vaccine decision-making.

Xia Y, Tunis MC, Frenette C, Katz K, Amaratunga K, Rose SR, House A, Quach C.

Can Commun Dis Rep. 2019 Jul 4;45(7-8):191-211. doi: 10.14745/ccdr.v45i78a04. eCollection 2019 Jul 4.

3.

Results from the Canadian Nosocomial Infection Surveillance Program for detection of carbapenemase-producing Acinetobacter spp. in Canadian hospitals, 2010-16.

Boyd DA, Mataseje LF, Pelude L, Mitchell R, Bryce E, Roscoe D, Embree J, Katz K, Kibsey P, Lavallee C, Simor AE, Taylor G, Turgeon N, Langley JM, Amaratunga K, Mulvey MR; Canadian Nosocomial Infection Surveillance Program .

J Antimicrob Chemother. 2019 Feb 1;74(2):315-320. doi: 10.1093/jac/dky416.

PMID:
30312401
4.

The evolving epidemiology of Clostridium difficile infection in Canadian hospitals during a postepidemic period (2009-2015).

Katz KC, Golding GR, Choi KB, Pelude L, Amaratunga KR, Taljaard M, Alexandre S, Collet JC, Davis I, Du T, Evans GA, Frenette C, Gravel D, Hota S, Kibsey P, Langley JM, Lee BE, Lemieux C, Longtin Y, Mertz D, Mieusement LMD, Minion J, Moore DL, Mulvey MR, Richardson S, Science M, Simor AE, Stagg P, Suh KN, Taylor G, Wong A, Thampi N; Canadian Nosocomial Infection Surveillance Program.

CMAJ. 2018 Jun 25;190(25):E758-E765. doi: 10.1503/cmaj.180013.

5.

Mycobacterium chimaera infections in post-operative patients exposed to heater-cooler devices: An overview.

Ogunremi T, Taylor G, Johnston L, Amaratunga K, Muller M, Coady A, Defalco K, Dunn K, Johnstone J, Smith S, Embree J, Henry B, Stafford J; Infection Prevention; Control Expert Working Group.

Can Commun Dis Rep. 2017 May 4;43(5):107-113. eCollection 2017 May 4.

6.

Response to Alert on Possible Infections with Mycobacterium chimaera From Contaminated Heater-Cooler Devices in Hospitals Participating in the Canadian Nosocomial Infection Surveillance Program (CNISP).

Mertz D, Macri J, Hota S, Amaratunga K, Davis I, Johnston L, Lee B, Pelude L, Science M, Smith S, Wong A; Canadian Nosocomial Infection Surveillance Program (CNISP).

Infect Control Hosp Epidemiol. 2018 Apr;39(4):482-484. doi: 10.1017/ice.2018.24. Epub 2018 Feb 28.

PMID:
29488454
7.

A Kinome RNAi Screen in Drosophila Identifies Novel Genes Interacting with Lgl, aPKC, and Crb Cell Polarity Genes in Epithelial Tissues.

Parsons LM, Grzeschik NA, Amaratunga K, Burke P, Quinn LM, Richardson HE.

G3 (Bethesda). 2017 Aug 7;7(8):2497-2509. doi: 10.1534/g3.117.043513.

8.

A shorter treatment regimen for latent tuberculosis infection holds promise for at-risk Canadians.

Pease C, Amaratunga KR, Alvarez GG.

Can Commun Dis Rep. 2017 Mar 2;43(3-4):67-71. eCollection 2017 Mar 2.

9.

Periprosthetic Infection following Primary Hip and Knee Arthroplasty: The Impact of Limiting the Postoperative Surveillance Period.

Roth VR, Mitchell R, Vachon J, Alexandre S, Amaratunga K, Smith S, Vearncombe M, Davis I, Mertz D, Henderson E, John M, Johnston L, Lemieux C, Pelude L, Gravel D; Canadian Nosocomial Infection Surveillance Program.

Infect Control Hosp Epidemiol. 2017 Feb;38(2):147-153. doi: 10.1017/ice.2016.256. Epub 2016 Nov 11.

PMID:
27834161
10.

Advancing surveillance of antimicrobial resistance: Summary of the 2015 CIDSC Report.

Amaratunga K, Tarasuk J, Tsegaye L, Archibald CP; 2015 Communicable and Infectious Disease Steering Committee (CIDSC); Antimicrobial Resistance (AMR) Surveillance Task Group.

Can Commun Dis Rep. 2016 Nov 3;42(11):232-237. eCollection 2016 Nov 3.

11.

Results from the Canadian Nosocomial Infection Surveillance Program on Carbapenemase-Producing Enterobacteriaceae, 2010 to 2014.

Mataseje LF, Abdesselam K, Vachon J, Mitchel R, Bryce E, Roscoe D, Boyd DA, Embree J, Katz K, Kibsey P, Simor AE, Taylor G, Turgeon N, Langley J, Gravel D, Amaratunga K, Mulvey MR.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6787-6794. doi: 10.1128/AAC.01359-16. Print 2016 Nov.

12.

Schizotypy and mindfulness: Magical thinking without suspiciousness characterizes mindfulness meditators.

Antonova E, Amaratunga K, Wright B, Ettinger U, Kumari V.

Schizophr Res Cogn. 2016 May 31;5:1-6. doi: 10.1016/j.scog.2016.05.001. eCollection 2016 Sep.

13.

Primary care pearls to help eliminate tuberculosis in Canada.

Amaratunga KR, Alvarez GG.

Can Commun Dis Rep. 2016 Mar 3;42(3):63-67. eCollection 2016 Mar 3.

14.

Site-directed mutagenesis and X-ray crystallography of the PQQ-containing quinoprotein methanol dehydrogenase and its electron acceptor, cytochrome c(L).

Afolabi PR, Mohammed F, Amaratunga K, Majekodunmi O, Dales SL, Gill R, Thompson D, Cooper JB, Wood SP, Goodwin PM, Anthony C.

Biochemistry. 2001 Aug 21;40(33):9799-809.

PMID:
11502173
15.

Erratum to "The methanol oxidation genes mxaFJGIR (S) ACKLD in Methylobacterium extorquens" [FEMS Microbiol. Lett. 146 (1997) 31-38].

Amaratunga K, Goodwin PM, O'Connor CD, Anthony C.

FEMS Microbiol Lett. 1997 May 1;150(1):175-7. No abstract available.

16.

The methanol oxidation genes mxaFJGIR (S) ACKLD in Methylobacterium extorquens.

Amaratunga K, Goodwin PM, O'Connor CD, Anthony C.

FEMS Microbiol Lett. 1997 Jan 1;146(1):31-8. Erratum in: FEMS Microbiol Lett. 1997 May 1;150(1):175-7.

17.

Pure choriocarcinoma of ovary, probably non-gestational in origin.

Goonewardene M, Amaratunga K.

Ceylon Med J. 1995 Mar;40(1):49-50. No abstract available.

PMID:
7781102

Supplemental Content

Loading ...
Support Center